Logo image of AGYS

AGILYSYS INC (AGYS) Stock Fundamental Analysis

NASDAQ:AGYS - Nasdaq - US00847J1051 - Common Stock - Currency: USD

115.13  +0.14 (+0.12%)

Fundamental Rating

5

Taking everything into account, AGYS scores 5 out of 10 in our fundamental rating. AGYS was compared to 282 industry peers in the Software industry. While AGYS has a great profitability rating, there are some minor concerns on its financial health. AGYS is valued quite expensively, but it does show have an excellent growth rating. With these ratings, AGYS could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

AGYS had positive earnings in the past year.
In the past year AGYS had a positive cash flow from operations.
AGYS had positive earnings in 4 of the past 5 years.
Each year in the past 5 years AGYS had a positive operating cash flow.
AGYS Yearly Net Income VS EBIT VS OCF VS FCFAGYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.35%, AGYS is in the better half of the industry, outperforming 75.89% of the companies in the same industry.
The Return On Equity of AGYS (8.73%) is better than 76.60% of its industry peers.
AGYS has a better Return On Invested Capital (7.86%) than 80.85% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AGYS is below the industry average of 12.15%.
The 3 year average ROIC (7.16%) for AGYS is below the current ROIC(7.86%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.35%
ROE 8.73%
ROIC 7.86%
ROA(3y)11.61%
ROA(5y)4.91%
ROE(3y)17.82%
ROE(5y)7.29%
ROIC(3y)7.16%
ROIC(5y)N/A
AGYS Yearly ROA, ROE, ROICAGYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

AGYS has a Profit Margin of 8.43%. This is in the better half of the industry: AGYS outperforms 75.89% of its industry peers.
AGYS's Profit Margin has improved in the last couple of years.
AGYS's Operating Margin of 10.18% is fine compared to the rest of the industry. AGYS outperforms 76.95% of its industry peers.
AGYS's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 62.40%, AGYS is in line with its industry, outperforming 42.91% of the companies in the same industry.
AGYS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.18%
PM (TTM) 8.43%
GM 62.4%
OM growth 3Y22.98%
OM growth 5YN/A
PM growth 3Y43.88%
PM growth 5YN/A
GM growth 3Y-0.01%
GM growth 5Y4.37%
AGYS Yearly Profit, Operating, Gross MarginsAGYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

5

2. Health

2.1 Basic Checks

AGYS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AGYS has been increased compared to 1 year ago.
Compared to 5 years ago, AGYS has more shares outstanding
The debt/assets ratio for AGYS is higher compared to a year ago.
AGYS Yearly Shares OutstandingAGYS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
AGYS Yearly Total Debt VS Total AssetsAGYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 12.88 indicates that AGYS is not in any danger for bankruptcy at the moment.
AGYS has a Altman-Z score of 12.88. This is amongst the best in the industry. AGYS outperforms 90.07% of its industry peers.
AGYS has a debt to FCF ratio of 0.46. This is a very positive value and a sign of high solvency as it would only need 0.46 years to pay back of all of its debts.
AGYS's Debt to FCF ratio of 0.46 is fine compared to the rest of the industry. AGYS outperforms 78.72% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that AGYS is not too dependend on debt financing.
AGYS has a Debt to Equity ratio of 0.09. This is comparable to the rest of the industry: AGYS outperforms 54.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.46
Altman-Z 12.88
ROIC/WACC0.77
WACC10.27%
AGYS Yearly LT Debt VS Equity VS FCFAGYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

2.3 Liquidity

AGYS has a Current Ratio of 1.11. This is a normal value and indicates that AGYS is financially healthy and should not expect problems in meeting its short term obligations.
AGYS's Current ratio of 1.11 is on the low side compared to the rest of the industry. AGYS is outperformed by 68.44% of its industry peers.
AGYS has a Quick Ratio of 1.07. This is a normal value and indicates that AGYS is financially healthy and should not expect problems in meeting its short term obligations.
AGYS has a Quick ratio of 1.07. This is in the lower half of the industry: AGYS underperforms 69.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.07
AGYS Yearly Current Assets VS Current LiabilitesAGYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

8

3. Growth

3.1 Past

AGYS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.33%, which is quite impressive.
AGYS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 47.96% yearly.
Looking at the last year, AGYS shows a quite strong growth in Revenue. The Revenue has grown by 16.07% in the last year.
Measured over the past years, AGYS shows a quite strong growth in Revenue. The Revenue has been growing by 11.38% on average per year.
EPS 1Y (TTM)30.33%
EPS 3Y23.91%
EPS 5Y47.96%
EPS Q2Q%10%
Revenue 1Y (TTM)16.07%
Revenue growth 3Y19.23%
Revenue growth 5Y11.38%
Sales Q2Q%20.73%

3.2 Future

The Earnings Per Share is expected to grow by 16.20% on average over the next years. This is quite good.
AGYS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.76% yearly.
EPS Next Y6.79%
EPS Next 2Y16.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.89%
Revenue Next 2Y15.61%
Revenue Next 3Y17.93%
Revenue Next 5Y21.76%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AGYS Yearly Revenue VS EstimatesAGYS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
AGYS Yearly EPS VS EstimatesAGYS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

AGYS is valuated quite expensively with a Price/Earnings ratio of 72.41.
AGYS's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.03. AGYS is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 54.66 indicates a quite expensive valuation of AGYS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AGYS is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 36.28. AGYS is valued rather expensively when compared to this.
Industry RankSector Rank
PE 72.41
Fwd PE 54.66
AGYS Price Earnings VS Forward Price EarningsAGYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

AGYS's Enterprise Value to EBITDA is on the same level as the industry average.
AGYS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 61.67
EV/EBITDA 88.05
AGYS Per share dataAGYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
AGYS has a very decent profitability rating, which may justify a higher PE ratio.
AGYS's earnings are expected to grow with 16.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)10.66
PEG (5Y)1.51
EPS Next 2Y16.2%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AGYS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AGILYSYS INC

NASDAQ:AGYS (8/6/2025, 3:01:40 PM)

115.13

+0.14 (+0.12%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-21 2025-07-21/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners101.17%
Inst Owner Change1.92%
Ins Owners4.61%
Ins Owner Change0.15%
Market Cap3.23B
Analysts85
Price Target125.87 (9.33%)
Short Float %5.68%
Short Ratio4.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)46.94%
Min EPS beat(2)8.77%
Max EPS beat(2)85.11%
EPS beat(4)4
Avg EPS beat(4)30.36%
Min EPS beat(4)8.77%
Max EPS beat(4)85.11%
EPS beat(8)8
Avg EPS beat(8)27.71%
EPS beat(12)12
Avg EPS beat(12)25.32%
EPS beat(16)15
Avg EPS beat(16)23.95%
Revenue beat(2)1
Avg Revenue beat(2)-2.41%
Min Revenue beat(2)-6.77%
Max Revenue beat(2)1.95%
Revenue beat(4)1
Avg Revenue beat(4)-2.27%
Min Revenue beat(4)-6.77%
Max Revenue beat(4)1.95%
Revenue beat(8)2
Avg Revenue beat(8)-1.38%
Revenue beat(12)5
Avg Revenue beat(12)-0.5%
Revenue beat(16)7
Avg Revenue beat(16)-0.83%
PT rev (1m)5.7%
PT rev (3m)1.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.99%
EPS NY rev (1m)-0.65%
EPS NY rev (3m)-0.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.01%
Revenue NY rev (1m)0.32%
Revenue NY rev (3m)-2.56%
Valuation
Industry RankSector Rank
PE 72.41
Fwd PE 54.66
P/S 11.71
P/FCF 61.67
P/OCF 58.56
P/B 12.14
P/tB 50.09
EV/EBITDA 88.05
EPS(TTM)1.59
EY1.38%
EPS(NY)2.11
Fwd EY1.83%
FCF(TTM)1.87
FCFY1.62%
OCF(TTM)1.97
OCFY1.71%
SpS9.83
BVpS9.48
TBVpS2.3
PEG (NY)10.66
PEG (5Y)1.51
Profitability
Industry RankSector Rank
ROA 5.35%
ROE 8.73%
ROCE 8.68%
ROIC 7.86%
ROICexc 10.16%
ROICexgc 52.03%
OM 10.18%
PM (TTM) 8.43%
GM 62.4%
FCFM 18.99%
ROA(3y)11.61%
ROA(5y)4.91%
ROE(3y)17.82%
ROE(5y)7.29%
ROIC(3y)7.16%
ROIC(5y)N/A
ROICexc(3y)15.95%
ROICexc(5y)N/A
ROICexgc(3y)439.05%
ROICexgc(5y)N/A
ROCE(3y)7.91%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-16.81%
ROICexc growth 5YN/A
OM growth 3Y22.98%
OM growth 5YN/A
PM growth 3Y43.88%
PM growth 5YN/A
GM growth 3Y-0.01%
GM growth 5Y4.37%
F-Score5
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.46
Debt/EBITDA 0.67
Cap/Depr 34.79%
Cap/Sales 1.01%
Interest Coverage 20.35
Cash Conversion 152.87%
Profit Quality 225.38%
Current Ratio 1.11
Quick Ratio 1.07
Altman-Z 12.88
F-Score5
WACC10.27%
ROIC/WACC0.77
Cap/Depr(3y)131.65%
Cap/Depr(5y)90.98%
Cap/Sales(3y)2.69%
Cap/Sales(5y)1.97%
Profit Quality(3y)162.49%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.33%
EPS 3Y23.91%
EPS 5Y47.96%
EPS Q2Q%10%
EPS Next Y6.79%
EPS Next 2Y16.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.07%
Revenue growth 3Y19.23%
Revenue growth 5Y11.38%
Sales Q2Q%20.73%
Revenue Next Year13.89%
Revenue Next 2Y15.61%
Revenue Next 3Y17.93%
Revenue Next 5Y21.76%
EBIT growth 1Y59.04%
EBIT growth 3Y46.64%
EBIT growth 5YN/A
EBIT Next Year188.57%
EBIT Next 3Y75.6%
EBIT Next 5Y56.79%
FCF growth 1Y30.67%
FCF growth 3Y24.23%
FCF growth 5Y48.7%
OCF growth 1Y14.41%
OCF growth 3Y24.6%
OCF growth 5Y39.06%